Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Apr;31(4):783-4.

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study

Sally Aspegren Kendall  1 , Malika Lone Chenoufi Schaadt, Lykke Bjerglund Graff, Irene Wittrup, Hanne Malmskov, Kim Krogsgaard, Else-Marie Bartels, Henning Bliddal, Bente Danneskiold-Samsøe
Affiliations
  • PMID: 15088307
Clinical Trial

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study

Sally Aspegren Kendall et al. J Rheumatol. 2004 Apr.

Abstract

Objective: To investigate the effect of an antiviral compound, valacyclovir, on pain and tenderness in patients with the fibromyalgia (FM) syndrome.

Methods: Sixty patients were randomized into a double blind, placebo controlled 6 week trial. Primary outcome was pain intensity change (on visual analog scale). Secondary outcome measures were tender points (myalgic score) and Fibromyalgia Impact Questionnaire (FIQ).

Results: Fifty-two patients completed the study. The numbers of dropouts due to adverse events were equal in valacyclovir (2) and placebo (2) groups. The effect of valacyclovir on pain and tenderness and FIQ did not differ from placebo.

Conclusion: Valacyclovir cannot be recommended as a therapy for FM at this point.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources